<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01323556</url>
  </required_header>
  <id_info>
    <org_study_id>AH 11.2009</org_study_id>
    <nct_id>NCT01323556</nct_id>
  </id_info>
  <brief_title>Mechanisms of Panic Disorders Treatment</brief_title>
  <official_title>Mechanisms of CBT-Treatment Effects in Patients With Panic Disorder and Panic Disorder With Agoraphobia: The Role of Interoceptive Exposure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Medicine Greifswald</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigation of mechanisms of exposure based learning by

        1. Investigating the effects of fear augmentation by interoceptive exposure during in vivo
           exposure

        2. Disentangling the effects of interoceptive exposure exercises in panic disorder
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study aims on investigating the effect of fear augmentation during in-vivo exposure by
      adding interoceptive exposure (e.g., hyperventilation) in PD/AG patients. By comparing the
      fear augmentation group with the therapist-guided CBT exposure, and by measuring autonomic
      arousal during and between exposure sessions, it will be possible to study the mechanisms of
      exposure based learning. A second aim is to disentangle effects of specific interoceptive
      exposure exercises (e.g., respiratory vs. vestibular stimulation). Finally, by including
      patients without agoraphobic avoidance it will be possible to investigate whether
      interoceptive exposure alone will have any effect. This might open the door for early
      interventions for individuals after experiencing an initial panic attack to prevent the
      development of a severe panic disorder with agoraphobic avoidance.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">May 2012</completion_date>
  <primary_completion_date type="Anticipated">October 2011</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hamilton Anxiety Rating Scale (HARS)</measure>
    <time_frame>up to 32 weeks (follow up)</time_frame>
    <description>structured clinician rating assessing the severity of an anxiety disorder</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinician Global Impression Scale (CGI)</measure>
    <time_frame>up to 32 weeks (follow up)</time_frame>
    <description>clinician rating assessing the severity of panic disorder and agoraphobia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Panic and Agoraphobia Scale (PAS)</measure>
    <time_frame>up to 32 weeks (follow up)</time_frame>
    <description>PAS is self-rating assessing panic disorder and agoraphobia severity with five factor analytic derived subscale scores (panic attacks, anticipatory anxiety, agoraphobic avoidance, health concerns, functional impairment) and a total score indicating the global severity. The questionnaire was specifically developed for monitoring changes during psychotherapy or psychopharmacological treatments.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mobility Inventory</measure>
    <time_frame>up to 32 weeks (follow up)</time_frame>
    <description>Self-rating assessing the extent of situational avoidance. The questionnaire comprises 27 situations that have to be evaluated in regard to frequency of avoidance, when alone or when accompanied.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of panic attacks</measure>
    <time_frame>up to 32 weeks (follow up)</time_frame>
    <description>Number of panic attacks experienced during the last week is assessed.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Panic Disorder</condition>
  <condition>Agoraphobia</condition>
  <condition>Panic Attacks</condition>
  <arm_group>
    <arm_group_label>Exposure with fear augmentation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>exposure-based CBT, including interoceptive exposure and in-vivo exposure with fear augmentation by interoceptive exercises (e.g. hyperventilation)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exposure without fear augmentation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>exposure-based CBT, including interoceptive and in-vivo exposure without fear augmentation during in-vivo exposure</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioural Therapy (CBT)</intervention_name>
    <description>12 sessions of CBT including psychoeducation, behavioral analyses, interoceptive exposure and in-vivo exposure with interoceptive exposure during in vivo exposure</description>
    <arm_group_label>Exposure with fear augmentation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioural Therapy (CBT)</intervention_name>
    <description>12 sessions of CBT including psychoeducation, behavioral analyses, interoceptive exposure and in-vivo exposure without additional fear augmenting strategies</description>
    <arm_group_label>Exposure without fear augmentation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-65 years old

          -  Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
             diagnosis of panic disorder, panic disorder with agoraphobia OR initial panic attacks

          -  CGI ≥ 4 (except persons with initial panic attacks)

          -  Informed Consent

        Exclusion Criteria:

          -  Acute suicidality

          -  Current substance use disorder

          -  Lifetime diagnosis of psychotic disorders, bipolar disorders, borderline personality
             disorders

          -  Severe medical condition (chronic conditions)

          -  Current psychotherapeutic or psychopharmacological treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alfons O. Hamm, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Psychology Ernst-Moritz-Arndt-University Greifswald Franz-Mehring-Str. 47; 17487 Greifswald, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Lang, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Center for Clinical Psychology and Rehabilitation/ Christoph-Dornier-Foundation for Clinical Psychology University Bremen Grazer Str. 2b 28359 Bremen, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexander L. Gerlach, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Institute for Clinical Psychology and Psychotherapy WWU Münster Fliednerstr. 21 48149 Münster, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tilo Kirchner, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Psychiatry und Psychotherapy Philipps-University Marburg Rudolf-Bultmann- Straße 8 35039 Marburg, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Georg W. Alpers, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Institute for Biological Psychology, Clinical Psychology and Psychotherapy University Würzburg Marcusstrasse 9-11 97070 Würzburg, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alfons O Hamm, PhD</last_name>
    <phone>+49 (0)3834-863716</phone>
    <email>hamm@uni-greifswald.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Prof. Dr. Alfons Hamm</name>
      <address>
        <city>Greifswald</city>
        <zip>17489</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alfons O. Hamm, Prof. Dr.</last_name>
      <phone>+49 (0)3834-863716</phone>
      <email>hamm@uni-greifswald.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.paniknetz.de/</url>
  </link>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 3, 2011</study_first_submitted>
  <study_first_submitted_qc>March 24, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2011</study_first_posted>
  <last_update_submitted>April 8, 2011</last_update_submitted>
  <last_update_submitted_qc>April 8, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 11, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. A. Hamm</name_title>
    <organization>University of Greifswald, Department of Clinical Psychology</organization>
  </responsible_party>
  <keyword>Panic disorder</keyword>
  <keyword>agoraphobia</keyword>
  <keyword>panic attacks</keyword>
  <keyword>exposure based learning</keyword>
  <keyword>interoceptive exposure exercises</keyword>
  <keyword>fear augmentation</keyword>
  <keyword>in vivo exposure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Panic Disorder</mesh_term>
    <mesh_term>Agoraphobia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

